可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Bozkurt B,Kribbs SB,Clubb FJ Jr,et al.Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats[J]. Circulation,1998,97(14):1382-1391.
[2]Seta Y,Shan K,Bozkurt B,et al.Basic mechanisms in heart failure:the cytokine hypothesis[J].J Card Fail,1996,2(3):243-249.
[3]JKrum H,Gilbert RE.Demographics and concomitant disorders in heart failure[J].Lancet,2003,362(9378):147-158.
[4]Niebauer J,Volk HD,Kemp M,et al.Endotoxin and immune activation in chronic heart failure:a prospective cohort study[J].Lancet,1999,353(9167):1838-1842.
[5]Krack A,Richartz BM,Gastmann A,et al.Studies on intragastric PCO2 at rest and during exercise as a marker of intestinal perfusion in patients with chronic heart failure[J].Eur J Heart Fail European journal of heart failure,2004,6(4):403-407.
[6]Anker SD,Ponikowski P,Varney S,et al.Wasting as independent risk factor for mortality in chronic heart failure[J].Lancet,1997,349(9058):1050-1053.
[7]Ahlman H,Nilsson.The gut as the largest endocrine organ in the body[J].Ann Oncol,2001,12(Suppl 2):S63-S68.
[8]Liao Y,Asakura M,Takashima S,et al.Amlodipine ameliorates myocardial hypertrophy by inhibiting EGFR phosphorylation[J].Biochem Biophys Res Commun,2005,327(4):1083-1087.
[9]Hasper D,Hummel M,Kleber FX,et al.Systemic inflammation in patients with heart failure[J].Eur Heart J,1998,19(5):761-765.
[10]Woldbaek PR,Tonnessen T,Henriksen UL,et al.Increased cardiac IL-18 mRNA, pro-IL-18 and plasma IL-18 after myocardial infarction in the mouse; a potential role in cardiac dysfunction[J].Cardiovasc Res,2003,59(1):122-131.
[11]Rauchhaus M,Doehner W,Francis DP,et al.Plasma cytokine parameters and mortality in patients with chronic heart failure[J].Circulation,2000,102(25):3060-3067.
[12]Torre-Amione G,Kapadia S,Benedict C,et al.Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD)[J].J Am Coll Cardiol,1996,27(5):1201-1206.
[13]Mann DL.Inflammatory mediators and the failing heart:past,present, and the foreseeable future[J].Circ Res,2002,91(11):988-998.
[14]Krack A,Sharma R,Figulla HR,et al.The importance of the gastrointestinal system in the pathogenesis of heart failure[J].Eur Heart J,2005,26(22):2368-2374.
[15]Sandek A,Rauchhaus M,Anker SD,et al.The emerging role of the gut in chronic heart failure[J].Curr Opin Clin Nutr Metab Care,2008,11(5):632-639.
[16]Peschel T,Schonauer M,Thiele H,et al.Invasive assessment of bacterial endotoxin and inflammatory cytokines in patients with acute heart failure[J].Eur J Heart Fail,2003,5(5):609-614.
[17]Conraads VM,Jorens PG,De Clerck LS,et al.Selective intestinal decontamination in advanced chronic heart failure: a pilot trial[J].Eur J Heart Fail,2004,6(4):483-491.
[18]Sanada S,Hakuno D,Higgins LJ,et al.IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system[J].J Clin Invest,2007,117(6):1538-1549.